Luebeck, Germany

Thorsten Hanhoff

This inventor holds 1 USPTO granted patent. Top assignee: Euroimmun Medizinische Labordiagnostika Ag. Active years: 2020.


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thorsten Hanhoff: Innovator in Capillary Vessel Technology

Introduction

Thorsten Hanhoff is a notable inventor based in Lübeck, Germany. He has made significant contributions to the field of medical diagnostics through his innovative work. His expertise and dedication have led to the development of a unique patent that enhances laboratory diagnostics.

Latest Patents

Thorsten Hanhoff holds a patent for a capillary vessel, which is designed to improve the efficiency and accuracy of laboratory tests. This invention is crucial for advancing medical diagnostics and has the potential to impact various healthcare applications. He has 1 patent to his name, showcasing his innovative capabilities.

Career Highlights

Hanhoff is currently employed at Euroimmun Medizinische Labordiagnostika AG, a company renowned for its contributions to medical laboratory diagnostics. His role at Euroimmun allows him to work on cutting-edge technologies that enhance diagnostic processes. His career reflects a commitment to innovation and excellence in the medical field.

Collaborations

Throughout his career, Thorsten has collaborated with esteemed colleagues, including Alexander Kowtun and Winfried Stoecker. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medical technology.

Conclusion

Thorsten Hanhoff is a distinguished inventor whose work in capillary vessel technology is paving the way for advancements in medical diagnostics. His contributions to Euroimmun and collaborations with other professionals highlight his commitment to innovation in the healthcare sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…